Topics
Circumscribed astrocytic gliomas | Treatment | Optic gliomas
Home > Publications > Topics > Circumscribed astrocytic gliomas > Treatment > Optic gliomas
2026
Ruggiero A, Attinà G, Placidi G, D'Agostino E, Amato A,
Verdolotti T, Mastrangelo S, Falsini B.
Long-term
outcomes after a randomized phase II trial of nerve growth factor
eye drops for optic pathway gliomas: four-year follow-up findings
in children.
J
Neurooncol. 2026 Sep 1;179(2):67. doi:
10.1007/s11060-026-05777-z. PMID:
42681266. Trial
registration ID: NCT05733572. ˍ